Hooshware

ESTABLISHING NEURAL LINK...

Back to News Radar

FundingOct 23, 2026

AI drug development startup Pathos AI closes $237M investment

AI drug development startup Pathos AI has raised $237 million in a Series E funding round led by Bristol Myers Squibb, reaching a $3 billion valuation as it…

SiliconANGLE – AI Read original report

Investing

#Pathos AI#funding#cancer drugs#Series E#Bristol Myers Squibb#AI#Announced

Related ecosystem entities

Pathos AI company

Observed across 1 source

1 editorial report · 0 verified social mentions. The most authoritative report leads while later evidence completes the story.

SiliconANGLE – AIPrimary source

AI drug development startup Pathos AI closes $237M investment

Open report

BTC—

SYNCING

ETH—

SYNCING

NVDA—

SYNCING

MSFT—

SYNCING

Customize